SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:uu-532261"
 

Search: id:"swepub:oai:DiVA.org:uu-532261" > Identification of F...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Zeng, HuangJiaying Univ, Inst Hakka Med Bioresources, Med Coll, Meizhou 514031, Peoples R China.;Jiaying Univ, Dept Pharm, Med Coll, Huangtang Rd 146, Meizhou 514031, Guangdong, Peoples R China. (author)

Identification of FTY720 and COH29 as novel topoisomerase I catalytic inhibitors by experimental and computational studies

  • Article/chapterEnglish2024

Publisher, publication year, extent ...

  • Elsevier,2024
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-532261
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-532261URI
  • https://doi.org/10.1016/j.bioorg.2024.107412DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • The development of novel topoisomerase I (TOP1) inhibitors is crucial for overcoming the drawbacks and limitations of current TOP1 poisons. Here, we identified two potential TOP1 inhibitors, namely, FTY720 (a sphingosine 1-phosphate antagonist) and COH29 (a ribonucleotide reductase inhibitor), through experimental screening of known active compounds. Biological experiments verified that FTY720 and COH29 were nonintercalative TOP1 catalytic inhibitors that did not induce the formation of DNA-TOP1 covalent complexes. Molecular docking revealed that FTY720 and COH29 interacted favorably with TOP1. Molecular dynamics simulations revealed that FTY720 and COH29 could affect the catalytic domain of TOP1, thus resulting in altered DNA-binding cavity size. The alanine scanning and interaction entropy identified Arg536 as a hotspot residue. In addition, the bioinformatics analysis predicted that FTY720 and COH29 could be effective in treating malignant breast tumors. Biological experiments verified their antitumor activities using MCF-7 breast cancer cells. Their combinatory effects with TOP1 poisons were also investigated. Further, FTY720 and COH29 were found to cause less DNA damage compared with TOP1 poisons. The findings provide reliable lead compounds for the development of novel TOP1 catalytic inhibitors and offer new insights into the potential clinical applications of FTY720 and COH29 in targeting TOP1.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Zhang, ShengyuanJiaying Univ, Inst Hakka Med Bioresources, Med Coll, Meizhou 514031, Peoples R China. (author)
  • Nie, HuaJiaying Univ, Inst Hakka Med Bioresources, Med Coll, Meizhou 514031, Peoples R China. (author)
  • Li, JunhaoUppsala universitet,Kemisk och biomolekylär fysik(Swepub:uu)jonli333 (author)
  • Yang, JiunlongJiaying Univ, Inst Hakka Med Bioresources, Med Coll, Meizhou 514031, Peoples R China. (author)
  • Zhuang, YuanbeiJiaying Univ, Inst Hakka Med Bioresources, Med Coll, Meizhou 514031, Peoples R China. (author)
  • Huang, YingjieJiaying Univ, Inst Hakka Med Bioresources, Med Coll, Meizhou 514031, Peoples R China. (author)
  • Zeng, MiaoJiaying Univ, Inst Hakka Med Bioresources, Med Coll, Meizhou 514031, Peoples R China. (author)
  • Jiaying Univ, Inst Hakka Med Bioresources, Med Coll, Meizhou 514031, Peoples R China.;Jiaying Univ, Dept Pharm, Med Coll, Huangtang Rd 146, Meizhou 514031, Guangdong, Peoples R China.Jiaying Univ, Inst Hakka Med Bioresources, Med Coll, Meizhou 514031, Peoples R China. (creator_code:org_t)

Related titles

  • In:Bioorganic chemistry: Elsevier1470045-2068

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view